Skip to main content
Clinical Trials/NCT01061281
NCT01061281CompletedPhase 4

Evaluation of the Tecnis™ Multifocal and Crystalens™ Accommodating Intraocular Lenses

Innovative Medical1 site in 1 country40 target enrollmentStarted: March 1, 2010Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Phase 4
Status
Completed
Enrollment
40
Locations
1
Primary Endpoint
Refraction

Study Overview

Brief Summary

The purpose of this study is to compare the visual outcomes with bilateral implantation of Tecnis MF and Crystalens™ AO Aberration-free Accommodating intraocular lens (IOLs) 6 months after post cataract surgery.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Age 18 or greater
  • •Bilateral cataracts for which phacoemulsification extraction and posterior IOL implantation has been planned for both eyes
  • •Visual potential of 20/25 or better in each eye after cataract removal and IOL implantation
  • •Preoperative best-corrected distance visual acuity (BCDVA) worse than 20/40 Snellen
  • •Naturally dilated pupil size (in dim light) > 4.0 mm (with no dilation medications) for both eyes
  • •Preoperative corneal astigmatism of 1.0 D or less
  • •Clear intraocular media other than cataract
  • •Availability, willingness, and sufficient cognitive awareness to comply with examination procedures

Exclusion Criteria

  • •Use of systemic or ocular medications that may affect vision
  • •Acute or chronic disease or illness that would increase risk or confound study results (e.g. diabetes mellitus, immunocompromised, etc.)
  • •Subjects with diabetes mellitus
  • •Uncontrolled systemic or ocular disease
  • •History of ocular trauma or prior ocular surgery
  • •Amblyopia or strabismus
  • •Known pathology that may affect visual acuity; particularly retinal changes that affect vision (macular degeneration, cystoid macular edema, proliferative diabetic retinopathy, etc.)
  • •Diagnosed degenerative visual disorders (e.g. macular degeneration, or other retinal disorders) that are predicted to cause future acuity losses to a level of 20/30 or worse
  • •Subjects who may be expected to require retinal laser treatment or other surgical intervention
  • •Capsule or zonular abnormalities that may affect postoperative centration or tilt of the lens (e.g. pseudoexfoliation syndrome)
  • •Pupil abnormalities (non-reactive, tonic pupils, abnormally shaped pupils, or pupils that do not dilate at least 4.0 mm under mesopic/scotopic conditions)
  • •Contact lens usage within 6 months for PMMA contacts lenses, 1 month for gas permeable lenses or 1 week for extended-wear and daily-wear soft contact lenses
  • •Requiring an intraocular lens < 15.0 or > 26.0 diopters

Arms & Interventions

Tecnis MF IOL

Active Comparator

Intervention: Tecnis MF IOL (Device)

Crystalens AO IOL

Active Comparator

Intervention: Crystalens AO IOL (Device)

Outcomes

Primary Outcomes

Refraction

Time Frame: 1 year

Distance Visual Acuities

Time Frame: 1 year

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Industry

Study Sites (1)

Loading locations...

Similar Trials